Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 01, 2019

SELL
$22.78 - $29.08 $1.19 Million - $1.52 Million
-52,425 Closed
0 $0
Q2 2019

Aug 01, 2019

SELL
$15.0 - $22.49 $1.79 Million - $2.69 Million
-119,638 Reduced 69.53%
52,425 $1.15 Million
Q1 2019

May 02, 2019

BUY
$14.02 - $16.74 $179,343 - $214,138
12,792 Added 8.03%
172,063 $2.78 Million
Q3 2018

Nov 01, 2018

BUY
$12.21 - $16.61 $158,730 - $215,930
13,000 Added 8.89%
159,271 $2.5 Million
Q2 2018

Jul 31, 2018

BUY
$11.13 - $21.86 $1.63 Million - $3.2 Million
146,271 New
146,271 $2.16 Million

Others Institutions Holding ZYME

About Zymeworks Inc.


  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $863M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Wedge Capital Management L L P Portfolio

Follow Wedge Capital Management L L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

News

Stay updated on Wedge Capital Management L L P with notifications on news.